Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beyond Hydronephrosis: Perirenal Fluid on Screening Ultrasound in Patients With Renal Colic at a Basic Emergency Service.

Cureus·2026
Same author

Characterizing drug allergy management among allergists in Canada: a national survey study.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology·2025
Same author

Clinical Presentation, Triggers, Comorbidities, and Management of Anaphylaxis in the Elderly: A Cross-Sectional Study.

International archives of allergy and immunology·2025
Same author

Topological modes of variability of the wind-driven ocean circulation.

Chaos (Woodbury, N.Y.)·2025
Same author

Symptomatology and Management of Adult Anaphylaxis according to Trigger: A Cross-Sectional Study.

International archives of allergy and immunology·2024
Same author

Symptomatology and management of peanut anaphylaxis: A cross-sectional study.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2024
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

[Erythema multiforme : target deciphering].

Revue medicale suisse·2026
See all related articles

Related Experiment Video

Updated: Jun 14, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

[Statins and muscular side-effects].

Christine Brosteaux1, Juan Ruiz, Thierry Buclin

  • 1Consultation des lipides et de prévention cardiovasculaire, PMU, Lausanne.

Revue Medicale Suisse
|April 9, 2010
PubMed
Summary
This summary is machine-generated.

Statins effectively lower cholesterol but can cause muscle symptoms in 5-10% of patients. Managing statin-induced myopathy involves assessing symptom severity and creatine kinase levels to guide treatment decisions.

Related Experiment Videos

Last Updated: Jun 14, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Area of Science:

  • Cardiology
  • Pharmacology
  • Clinical Medicine

Background:

  • Statins are widely used for hypercholesterolemia and cardiovascular disease prevention.
  • Muscular symptoms are a common side effect of statin therapy, occurring in 5-10% of patients.
  • Serious muscle complications like myositis and rhabdomyolysis are rare but significant concerns.

Purpose of the Study:

  • To review current management strategies for statin-induced myopathy.
  • To provide guidance on evaluating symptom severity and creatine kinase levels.
  • To discuss alternative treatment options when statin discontinuation is considered.

Main Methods:

  • Literature review of clinical practice guidelines and research studies.
  • Analysis of diagnostic criteria for statin-induced myopathy.
  • Synthesis of evidence-based recommendations for patient management.

Main Results:

  • Statin-induced myopathy management hinges on symptom intensity and creatine kinase (CK) levels.
  • Discontinuation of statin therapy is guided by the severity of myopathy.
  • Alternative lipid-lowering strategies exist for patients intolerant to statins.

Conclusions:

  • Effective management of statin-induced muscle complaints is crucial for patient adherence and cardiovascular risk reduction.
  • A systematic approach to diagnosis and treatment is necessary.
  • Further research may refine management protocols for statin-associated muscle symptoms.